An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators.
about
ARID1a-DNA interactions are required for promoter occupancy by SWI/SNFPITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitroInhibition of NF-AT-dependent transcription by NF-kappa B: implications for differential gene expression in T helper cell subsetsAbsolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytesMitotic inactivation of a human SWI/SNF chromatin remodeling complexUpstream region of rat serum albumin gene promoter contributes to promoter activity: presence of functional binding site for hepatocyte nuclear factor-3INSIG1 influences obesity-related hypertriglyceridemia in humans.Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway.An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells.Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levelsAn upstream YY1 binding site on the HIV-1 LTR contributes to latent infection.Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoterHuman immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected IndividualsAn in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter.Transcriptional effects of a lupus-associated polymorphism in the 5' untranslated region (UTR) of human complement receptor 2 (CR2/CD21)Cellular Recognition and Repair of Monofunctional-Intercalative Platinum--DNA AdductsA Case of Long-Term Seronegative Human Immunodeficiency Virus (HIV) Infection: The Importance of the Humoral Response to HIVCentral nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter.Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery.12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.Localization of the 12-O-tetradecanoylphorbol-13-acetate response of the human ornithine decarboxylase promoter to the TATA box.Rocaglamide-A Potentiates Osteoblast Differentiation by Inhibiting NF-κB Signaling.Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKRThe cis-acting elements involved in endonucleolytic cleavage of the 3' UTR of human IGF-II mRNAs bind a 50 kDa protein.Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1.Promoter control of translation in Xenopus oocytes.Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.Identification and characterization of a critical CP2-binding element in the human interleukin-4 promoter.Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest.The promoter of the salmon insulin-like growth factor I gene is activated by hepatocyte nuclear factor 1.CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes.Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene.Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation.Prostaglandin E2 signalling pathway in human T lymphocytes from healthy and conjunctiva basal cell carcinoma-bearing subjects.The liver-specific promoter of the human insulin-like growth factor-II gene contains two negative regulatory elements.
P2860
Q24302361-814F1C82-8245-4059-900E-FD62CB5ACF06Q24312133-F94E4925-CA6E-4C40-B3C4-DD51FB31A5C2Q24564467-E6AB01BA-4255-441E-BEFA-A1E5D9B69697Q24568326-3F2A9A6E-60CA-4EAC-93F2-FFA0D97200ADQ24596960-9C9FC6F6-543B-49FA-BBCE-E6E2DEB69A35Q28582053-7BF9B6FB-B6E4-487D-A6A4-980A1CCF39A9Q33728329-2B0F52FA-D123-4190-9C68-7B4695806C97Q33783417-EB87D689-C04C-468B-AEA8-18BD3F1A44F5Q33872322-E3B125DF-C30A-4B8B-8126-2EE448B5F5C3Q34064238-48644E17-607F-4FE1-BB84-C0E88813144CQ34545215-124474A8-EB63-48A2-ACFB-9F6297E8907DQ35015033-1F5410DB-29AB-4EE4-962F-994D1B16CD8DQ35222092-0112D463-CEDE-480E-B661-2812FE80FED8Q35862161-A3E5F531-FC61-41C2-A0B9-04B1421BA486Q36038655-726E6EC5-2242-43D0-B6D3-311CED591DF1Q36069170-9C2B698F-62F2-48FA-B4C1-84B37ABF25E9Q36106359-BA0DC185-8049-4233-B9B7-2711A550D9D4Q36460000-2E0EECE0-C86F-48B5-9268-F1281FB5ED34Q36548103-D21639F3-F665-4C91-9AA4-7CBCE52691DDQ36634412-5C0AC930-E233-4C22-A492-5707966D09F1Q38313605-ECCD1C51-7346-4ED7-8050-E66E226117DFQ38333075-0A455331-F0B3-490C-B474-A81DA2686514Q38346899-87E09D04-6BF3-4178-9F7C-E3E7F58A542CQ38352618-9327AE17-F8CF-4CBD-A27C-3A6614D50BA4Q38820948-878B9744-1E1C-4877-AE68-DA31A370DD36Q39456448-8DED6D41-A8E6-4DB3-B166-7AF56659E2A7Q39595632-09C7892E-D82D-4D31-9A9A-A66311CBC237Q39715846-6D6081A8-C3FA-4764-9301-C44ED3ECF077Q40037851-0240933F-87D8-465A-85CA-402771DB4746Q40048604-05848B3F-F9A6-455E-B682-7ADBC24163F1Q40392843-731F6FF7-F98D-4778-B0A4-71FFC9825455Q40418664-793E8468-0DFC-4D1E-821F-5982427E22C3Q40856752-C64552F5-6768-47F4-B0E9-88643BEB6D09Q41032886-C3148525-C5F9-47F9-8395-E6F38EEC95F0Q41379559-23D95116-B77C-44E8-A315-E9BE23ABCCA3Q41935503-F9187B35-303F-4E50-911E-829690732116Q42087613-D7E22C14-AD14-4F42-B0D4-35A933691F05Q42439479-640AB8F2-BBE3-4E5D-8DC5-2745D70BF962Q42510336-C18D1CD8-F610-4EB9-ACD5-64A8BCB2C5C5Q52199781-11C596FC-5A8E-4C71-9EBE-179C6487E43A
P2860
An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
An in vitro transcription anal ...... nt transcriptional activators.
@en
type
label
An in vitro transcription anal ...... nt transcriptional activators.
@en
prefLabel
An in vitro transcription anal ...... nt transcriptional activators.
@en
P2093
P2860
P356
P1476
An in vitro transcription anal ...... nt transcriptional activators.
@en
P2093
P2860
P304
P356
10.1128/MCB.11.4.1883
P407
P577
1991-04-01T00:00:00Z